伴赘生物形成感染性心内膜炎合并先天性心脏病并非介入治疗禁区

Interventional treatment may be an appropriate option for congenital heart disease complicated with infective endocarditis and vegetation

本文对一直以来学界认识的"伴赘生物形成感染性心内膜炎(IE)合并先天性心脏病只能通过外科手术治疗"的论断提出了不同看法,认为部分先天性心脏病并伴赘生物形成IE患者的治疗可以选择经皮导管介入的方法。伴赘生物形成IE在药物治疗的基础上,在合适的时机选择外科手术是传统的治疗方式。然而随着介入治疗技术的发展和适应证的不断拓展,对于部分经内科抗感染治愈的先天性心脏病合并伴赘生物形成IE患者,介入治疗也应成为一种合理的选择。

In this paper, we question a long-time recognition that surgery is the only way to the therapy for congenital heart disease complicated with infective endocarditis （IE） and vegetation. We think part of the patients with congenital heart disease suffering from IE and vegetation can choose percutaneous interventional treatment. The traditional strategy is to perform a surgery at an appropriate time on the basis of drug treatment. With the development of interventional techniques, the indications continue to expand. The interventional treatment becomes a reasonable option for some patients with congenital heart disease suffering from IE and vegetation after medications for anti-infection.